Moderna tests new mRNA shot against zika virus
NCT ID NCT04917861
Summary
This study tested the safety and immune response of an experimental mRNA vaccine (mRNA-1893) designed to prevent Zika virus infection. It involved 808 healthy adults, some with and some without prior exposure to similar viruses like dengue. Researchers compared two different vaccine doses to a placebo to see how well the body produced protective antibodies and to monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ZIKA VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benchmark Research - Fort Worth
Fort Worth, Texas, 76135, United States
-
Carribean Medical Research
San Juan, PR, 00918, Puerto Rico
-
Clinical Research Puerto Rico, Inc.
Guayama, PR, 00784, Puerto Rico
-
Clinical Research Puerto Rico, Inc.
San Juan, PR, 00909, Puerto Rico
-
GCM Medical Group, PSC
San Juan, PR, 00917, Puerto Rico
-
Johnson County Clin-Trials
Lenexa, Kansas, 66219, United States
-
Latin Clinical Trial Center, Inc.
San Juan, PR, 00909, Puerto Rico
-
Meridian Clinical Research (Sioux City, IA)
Sioux City, Iowa, 51106, United States
-
Ponce Medical School Foundation, Inc.
Ponce, PR, 00713, Puerto Rico
-
Ponce Medical School Foundation, Inc.
Ponce, PR, 00716, Puerto Rico
-
University of Puerto Rico
San Juan, PR, 00935, Puerto Rico
Conditions
Explore the condition pages connected to this study.